Open access
Open access
Powered by Google Translator Translator

Thoracic Surgery

RCT: Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer.

12 Apr, 2022 | 08:54h | UTC

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer – New England Journal of Medicine

News Release: Immunotherapy Plus Chemotherapy Before Surgery Improves Outcomes for Patients with Lung Cancer – Johns Hopkins Medicine

 

Commentary on Twitter

 

M-A: The clinical effect and safety of new preoperative fasting time guidelines for elective surgery.

12 Apr, 2022 | 09:51h | UTC

The clinical effect and safety of new preoperative fasting time guidelines for elective surgery: a systematic review and meta-analysis – Gland Surgery

Related:

An international multidisciplinary consensus statement on fasting before procedural sedation in adults and children – Anaesthesia

Does my hospitalized patient need an NPO-after-midnight order preoperatively?

ESPEN practical guideline: Clinical nutrition in surgery – “Preoperative fasting from midnight is unnecessary in most patients. Patients undergoing surgery, who are considered to have no specific risk of aspiration, shall drink clear fluids until 2 h before anesthesia. Solids shall be allowed until 6 h before anesthesia.”

Pro-Con Debate: 1- vs 2-Hour Fast for Clear Liquids Before Anesthesia in Children.

Editorial: The rationale for the recommendations of the European Pediatric Fasting Guideline – “the authors of the 2021 ESAIC pediatric guideline have found reasons to recommend reductions to the minimum fasting times for infant formula to 4 h, for breast milk to 3 h and for clear fluids to 1 h”.

Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration

Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology

Clear fluids fasting for elective paediatric anaesthesia: The European Society of Anaesthesiology consensus statement – European Journal of Anaesthesiology

Canadian Pediatric Anesthesia Society statement on clear fluid fasting for elective pediatric anesthesia – Canadian Journal of Anesthesia (free)

 

Empyema: ED presentation, evaluation, and management.

12 Apr, 2022 | 08:44h | UTC

Empyema: ED Presentation, Evaluation, and Management – emDocs

 

Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study.

31 Mar, 2022 | 08:23h | UTC

Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study – The BMJ

Editorial: Screening high risk populations for lung cancer

News Release: US lung cancer screening linked to earlier diagnosis and better survival – British Medical Journal

Related:

Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.

USPSTF Statement: begin screening for lung cancer at age 50 years instead of 55 years for patients at risk

Meta-analysis: Lung cancer screening using low-dose computed tomography reduces lung cancer–specific mortality, albeit with a tradeoff of likely overdiagnosis

 

Commentary on Twitter

 

Management of the secondary spontaneous pneumothorax: current guidance, controversies, and recent advances.

17 Mar, 2022 | 08:51h | UTC

Management of the Secondary Spontaneous Pneumothorax: Current Guidance, Controversies, and Recent Advances – Journal of Clinical Medicine

 

Multicenter comparative accuracy trial: Dynamic contrast-enhanced CT vs. positron emission tomography CT to characterize solitary pulmonary nodules.

16 Mar, 2022 | 08:51h | UTC

Abstract: Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling – Health Technology Assessment

Download: Full Report

 

Patient-centered care in thoracic surgery: a holistic approach—A review of the subjects of enhanced recovery after surgery, rehabilitation, pain management and patient-reported outcome measures in thoracic surgery.

15 Mar, 2022 | 08:16h | UTC

Patient-centred care in thoracic surgery: a holistic approach—A review of the subjects of enhanced recovery after surgery, rehabilitation, pain management and patient-reported outcome measures in thoracic surgery – Journal of Thoracic Disease

 

Review: Current surgical indications for non-small-cell lung cancer.

11 Mar, 2022 | 08:39h | UTC

Current Surgical Indications for Non-Small-Cell Lung Cancer – Cancers

 

RCT: Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions.

8 Mar, 2022 | 08:28h | UTC

Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 

RCT: In patients with early-stage lung cancer, video-assisted thoracoscopic lobectomy is associated with better recovery of physical function at 5 weeks.

3 Mar, 2022 | 08:42h | UTC

Video-Assisted Thoracoscopic or Open Lobectomy in Early-Stage Lung Cancer – NEJM Evidence

 

Commentary on Twitter

 

SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumors.

3 Mar, 2022 | 08:08h | UTC

SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021) – Clinical and Translational Oncology

 

Guideline Update: Timing of elective surgery and risk assessment after SARS-CoV-2 infection – “The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting”.

1 Mar, 2022 | 08:58h | UTC

Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update – Anaesthesia

Related:

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of Covid-19.

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

 

Surgery students ‘losing dexterity to stitch patients’.

21 Feb, 2022 | 09:24h | UTC

Surgery students ‘losing dexterity to stitch patients’ – BBC

 

Malignant pleural effusions: a review of current guidelines and practices.

9 Feb, 2022 | 08:19h | UTC

Malignant Pleural Effusions—A Review of Current Guidelines and Practices – Journal of Clinical Medicine

Related: Meta-Analysis: Interventions for the Management of Malignant Pleural Effusions

 

Evaluation and management of traumatic pneumothorax: A Western Trauma Association critical decisions algorithm.

3 Feb, 2022 | 08:46h | UTC

Evaluation and management of traumatic pneumothorax: A Western Trauma Association critical decisions algorithm – Journal of Trauma and Acute Care Surgery

 

RCT: Sugemalimab improves progression-free survival vs. placebo in patients with metastatic non-small-cell lung cancer.

1 Feb, 2022 | 08:25h | UTC

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial – The Lancet Oncology (link to abstract – $ for full-text)

Related study: Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)

Commentaries:

Sugemalimab shows promise for locally advanced, metastatic NSCLC – Medicine Matters

Sugemalimab Boosts Outcomes in NSCLC – MedPage Today (free registration required)

 

Commentary on Twitter

https://twitter.com/NatRevClinOncol/status/1483839169839255554

 

Clinical characteristics and outcomes of patients with COVID-19–Associated Acute Respiratory Distress Syndrome who underwent lung transplant.

28 Jan, 2022 | 08:41h | UTC

Clinical Characteristics and Outcomes of Patients With COVID-19–Associated Acute Respiratory Distress Syndrome Who Underwent Lung Transplant – JAMA

Related: Cases of lung transplantation for Covid-19–related respiratory failure in the US were associated with a three-month survival of 95.6%.

 

M-A: Surgical management of rib fractures after blunt trauma.

28 Jan, 2022 | 08:02h | UTC

Surgical management of rib fractures after blunt trauma: a systematic review and meta-analysis of randomised controlled trials – Annals of The Royal College of Surgeons of England

 

Cases of lung transplantation for Covid-19–related respiratory failure in the US were associated with a three-month survival of 95.6%.

27 Jan, 2022 | 10:00h | UTC

Lung Transplantation for Covid-19–Related Respiratory Failure in the United States – New England Journal of Medicine

Commentaries:

New data on COVID-19 lung transplants – Cedars-Sinai Medical Center

~7 Percent of Lung Transplants Due to COVID-19 Respiratory Failure – HealthDay

 

Comprehensive review of chest tube management.

27 Jan, 2022 | 09:40h | UTC

Comprehensive Review of Chest Tube Management – JAMA Surgery (free for a limited period)

 

Review: Evaluating the patient with a pulmonary nodule.

20 Jan, 2022 | 08:56h | UTC

Evaluating the Patient With a Pulmonary Nodule: A Review – JAMA (free for a limited period)

Author Interview: Evaluation and Management of Patients With Pulmonary Nodules

 

ASCO Guideline: Management of stage III non–small-cell lung cancer.

18 Jan, 2022 | 09:12h | UTC

Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline – Journal of Clinical Oncology

 

RCT: Postoperative radiotherapy (PORT) did not increase disease-free survival compared with no PORT in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement.

8 Jan, 2022 | 22:38h | UTC

Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)

Commentaries:

Postoperative Radiotherapy for Patients With Completely Resected Stage IIIA NSCLC and N2 Involvement – The ASCO Post

Post-Operative Radiotherapy Not Tied to Better Disease-Free Survival in NSCLC – MedPage Today (free registration required)

 

Guideline: Prevention, diagnosis, and management of post-surgical mediastinitis in adults.

17 Dec, 2021 | 08:41h | UTC

Prevention, Diagnosis and Management of Post-Surgical Mediastinitis in Adults Consensus Guidelines of the Spanish Society of Cardiovascular Infections (SEICAV), the Spanish Society of Thoracic and Cardiovascular Surgery (SECTCV) and the Biomedical Research Centre Network for Respiratory Diseases (CIBERES) – Journal of Clinical Medicine

 

Modern day management of a unilateral pleural effusion.

9 Dec, 2021 | 09:58h | UTC

Modern day management of a unilateral pleural effusion – Clinical Medicine Journal

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.